Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.820
+0.040 (2.25%)
Aug 7, 2026, 1:57 PM EDT - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $77.63 million as of August 7, 2026. Its market cap has increased by 45.34% in one year.
Market Cap
77.63M
Enterprise Value
60.48M
1-Year Change
45.34%
Ranking
Category
Stock Price
$1.82
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $77.63M, a decrease of -37.72%. That is a compound annual growth rate of -8.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 77.63M | -37.32% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 80.47M |
| Alterity Therapeutics | 80.33M |
| Annovis Bio | 79.13M |
| Atara Biotherapeutics | 74.33M |
| Inovio Pharmaceuticals | 73.88M |
| Elicio Therapeutics | 73.64M |
| Spero Therapeutics | 73.53M |
| LeonaBio | 73.36M |